Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Norway / NCT04289415
Active, not recruiting Not applicable

From Addiction to Employment.

NCT04289415 · tracked via the Priya Life Science Norway tracker
Sponsor
Oslo University Hospital
Phase
Not applicable
Started
2020-03-01
Last updated
2024-04-04

Condition(s) studied

Substance Use Disorders

Investigational drug(s) / intervention(s)

Individual Placement and Support

Individual Placement and Support: Employment specialist will work together with the participants in accordance to the method IPS in order to help the participant obtain competitive employment

Study summary

Patients with substance use disorders have low employment rates and are to a large extent on the outside of the ordinary labor market. Individual Placement and Support (IPS) is an evidence based method developed to aid persons with severe mental disorders in obtaining ordinary work. IPS has been used clinically in the addiction field, but has been subject to little research. The trial "From addiction to employment" is a randomized controlled trial to investigate the effect of an IPS intervention on employment outcome among substance use disorder patients in specialized health care treatment in Oslo, Norway. The study is conducted at the Department for Substance Use Disorder Treatment at Oslo University Hospital. The trial begins to include patients March 1st 2020 and will include for two years, until February 28th 2022.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * In treatment, unemployed, want to obtain ordinary, competitive employment Exclusion Criteria: * coercive treatment that disables the patient to engage in the intervention

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department for Substance Use Treatment, Oslo University Hospital Oslo Norway

More Oslo University Hospital trials in Norway

Cervical Radiculopathy Trial Active, not recruiting
Nutrition Therapy in the Immature Infant (ImNuT) Active, not recruiting
The HIP Self-management Study Active, not recruiting
Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation Recruiting
Natural History Study of Retinitis Pigmentosa Type 11 Active, not recruiting

Other trials for the same condition

The Norwegian Addiction, Pain and Trauma Study Active, not recruiting
Improving Social Functioning in People With Substance Use and Mental Health Disorders Using VR Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04289415 on ClinicalTrials.gov ↗ ← All trials in Norway